EP2792677
Ný efnasambönd gagnleg í meðhöndlun á hrörnunar- og bólgusjúkdómum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.6.2010EP published:
26.4.2017EP application number:
14175887.0
EP translation filed:
17.7.2017Grant published:
15.8.2017EPO information:
European Patent Register
Max expiry date:
24.6.2030Expiry date:
24.6.2021
Title:
Novel compound useful for the treatment of degenerative and inflammatory diseases
Timeline
Today
25.6.2010EP application
26.4.2017EP Publication
17.7.2017Translation submitted
15.8.2017Registration published
24.6.2021Expires
Owner
Name:
Galapagos NVAddress:
Generaal De Wittelaan L11/A3, 2800, Mechelen, BE
Inventor
Name:
Blanc, JavierAddress:
Mechelen, BE
Name:
Menet, Christel Jeanne MarieAddress:
Mechelen, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
220685 PDate:
26.6.2009Country:
US
Number:
298188 PDate:
25.1.2010Country:
US
Classification
Categories:
C07D 471/04, A61K 31/437, A61P 29/00, A61P 35/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 26.5.2017
Expires: 24.6.2018
Payer: Örn Þór, slf.
Number: 9
Paid: 9.5.2018
Expires: 24.6.2019
Payer: Örn Þór, slf.
Number: 10
Paid: 8.5.2019
Expires: 24.6.2020
Payer: Árnason Faktor
Number: 11
Paid: 5.5.2020
Expires: 24.6.2021
Payer: Árnason Faktor ehf.